FOLFOX versus 5FU/Capecitabine/XRT

Disease Type – Rectal
Protocol Number: ALLIANCE – N1048
A phase II/III protocol of neoadjuvant FOLFOX with selective use of combination XRT in locally advanced Rectal Cancer – OPEN TO ENROLLMENT